Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: ZFP TF

Sangamo – zinc finger proteins therapeutics

Posted on by

Sangamo is a biopharma company focused on the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for unmet medical needs.

Sangamo – zinc finger proteins therapeutics

sangamo Continue reading →

Posted in Biotech Companies, Biotech Companies USA | Tagged AAV, adeno-associated virus, Alzheimer's disease, Alzheimers, Barrie Carter, CCR5, CERE-110, Ceregene, Ceregene Inc, Dale Ando, David Ichikawa, Edward Lanphier, Gabor Rubanyi, Geoffrey Nichol, glucocorticoid, hemophilia, HIV, Huntington, Huntington's Disease, John Larson, Judith Campisi, Keith Yamamoto, Kevin Struhl, Michael Gilman, Nasdaq Global Market, nerve growth factor, NGF, NGF-AAV, Paul Cleveland, Philip Gregory, Saira Ramasastry, Sangamo, Sangamo - zinc finger proteins therapeutics, SB-313, SB-728, SGMO, Sir Aaron Klug, Stephen Dilly, Steven Mento, Stewart Parker, Ward Wolff, William Ringo, ZFP, ZFP TF, ZFP TFs, ZFP Therapeutic, ZFP Therapeutics, ZFP transcription factor, ZFP transcription factors, ZFPs, zinc finger, zinc finger DNA binding protein, zinc finger DNA-binding proteins, zinc finger protein, zinc finger protein therapeutic, zinc finger proteins, zinc finger proteins therapeutics

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress